I am specifically looking at expensive treatments like cancer drugs (keytruda and similar) but any info is helpful.
Do they just charge a % over the cost they acquire the drugs, so the more expensive the drug the more expensive the markup?
Or is it based on the actual dollar cost of administrating the drugs, so more expensive drugs will have the same dollar amount markup as cheaper drugs if they have similar administrative costs/difficulty?
0 nhận xét:
Đăng nhận xét